期刊文献+

贝伐单抗辅助手术治疗严重增殖性糖尿病视网膜病变

下载PDF
导出
摘要 目的:观察贝伐单抗辅助手术治疗严重增殖性糖尿病视网膜病变的临床治疗效果.方法:在严重增殖性糖尿病视网膜病变患者总抽取87例作为试验样本,根据随机奇偶数法分成对照组(42例)和治疗组(45例)两组,均实施玻璃体切割术.对照组术前未给予贝伐单抗,治疗组则在术前10d予以贝伐单抗注射.结果:治疗组与对照组术后1个月、3个月、6个月、12个月的BCVA行比较,两组患者间的差异不显著,无统计学意义(P>0.05);术后两组并发症发生率行比较,治疗组低于对照组,P<0.05.结论:贝伐单抗辅助手术治疗可进一步提高严重增殖性糖尿病视网膜病变的临床效果,改善视力,减少并发症,具备在临床中推广的价值.
作者 徐春亭
机构地区 烟台解放军第
出处 《医学食疗与健康》 2020年第7期90-91,共2页 Medical Diet and Health
  • 相关文献

二级参考文献63

  • 1刘隽,梅妍,方林.糖尿病性视网膜病变的荧光造影及激光治疗[J].云南医药,2006,27(4):408-409. 被引量:2
  • 2熊毅彤,叶纹,孙莉.激光光凝治疗视网膜静脉阻塞的临床价值[J].眼科新进展,2007,27(3):210-212. 被引量:14
  • 3Ehrlich R, Harris A, Ciulla TA, et al . Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process. Acta Ophthalmol 2010;88(3) :279-291.
  • 4Hua W, Cao S, CuI J, et al . Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy. Can J Opthalmol 2013 ;48(2) :88.
  • 5Shah AR, Del Priore LV. Duration of action of intravitreal ranibizumab and bevacizumah in exudative AMD eyes based on macular volume measurements. Br J Ophthalmol 2009 ;98 ( 3 ) : 1027-1032.
  • 6Landa G, Amde W, Doshi V, et al. Comparative study of intravitreal bevacizumab versus ranibizumab in the treatment of neovascular age related macular degeneration. Ophthalmologica 2009 ;223 (6) :370-375.
  • 7Modarres M, Naseripour M, Falavarjani KG, et al. Intravitreal injection of 2.5mg versus 1.25mg bevacizumab for treatment of CNV associated with AMD. Retina 2009;29(3) :319-324.
  • 8Valmaggia C, Haueter I, Kloos P, et al. The treatment of ehoroidal neovascularizations in age- related macular degeneration using either Avastin or Lucentis. Klin Monatsbl Augenheilkd 2009 ;226(4) :294-298.
  • 9KOCAK N, OZOGUL C. The effects of intravitreally injected bevacizumab on the retina and retina pigment epithelium: ex- perimental in-vivo electron microscopic study in intact versus vitrectomized eyes [ J ]. Cent Eur J Med,2010,5 (6) :745-751.
  • 10SAXENA S,JAIN A. in "in vivo" histology of retina in bilat- eral chronic central serous chorioretinopathy after intravit- real bevacizumab [J].J Ocular Biol Dis Informatics , 2011,4 (4) :137-140.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部